EAGLE PHARMACEUTICALS, INC.·4

Jan 24, 6:13 PM ET

Tarriff Scott 4

4 · EAGLE PHARMACEUTICALS, INC. · Filed Jan 24, 2023

Insider Transaction Report

Form 4
Period: 2023-01-23
Tarriff Scott
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    2023-01-23$33.64/sh3,732$125,5441,572,147 total
Footnotes (1)
  • [F1]The disposition reported on this Form 4 represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION